Back

dr. M.J.J. (Marie-José) Mangen

Assistant Professor

  • Department of Public Health, Healthcare Innovation & Evaluation and Medical Humanities (PHM)

dr. M.J.J. (Marie-José) Mangen

Biography

Marie-Josée J. Mangen is an economist with special interest in public health, infectious diseases and food safety. She holds an MSc in animal science from the University of Bonn, Germany, and in Agricultural Economics and Marketing from Wageningen University, the Netherlands. She obtained her PhD at Wageningen University, the Netherlands in 2002. She then moved for a short-term project to the Livestock Information and Policy Branch at the Food and Agricultural Organization in Rome, Italy. From 2003 to 2004 she held a post-doc at the Agricultural Economic Research Institute and at the National Institute for Public Health and the Environment (RIVM) in the Netherlands where she participated as an economist on the CARMA (CAmpylobacter Risk Management and Assessment) project. She then worked at RIVM on various economic evaluations in the field of public health and infectious diseases. Since June 2008 she has an appointment as assistant professor at the University Medical Centre Utrecht, Julius Center for Health Science and Primary Care within the Health Technology Assessment group.

Side Activities

  • None

Fellowship and Awards

  • None

Research Output (71)

A social cost-benefit analysis of two One Health interventions to prevent toxoplasmosis

Suijkerbuijk Anita W M, Over Eelco A B, Opsteegh Marieke, Deng Huifang, Gils Paul F van, Bonačić Marinović Axel A, Lambooij Mattijs, Polder Johan J, Feenstra Talitha L, Giessen Joke W B van der, Wit G Ardine de, Mangen Marie-Josee J 1 mei 2019, In: PLoS ONE. 14

Disease burden of varicella versus other vaccine-preventable diseases before introduction of vaccination into the national immunisation programme in the Netherlands

van Lier Alies, de Gier Brechje, McDonald Scott A, Mangen Marie-Josée J, van Wijhe Maarten, Sanders Elisabeth A M, Kretzschmar Mirjam E, van Vliet Hans, de Melker Hester E mei 2019, In: Eurosurveillance. 24 , p. 1-10

Consumers' preferences for freezing of meat to prevent toxoplasmosis- A stated preference approach

Lambooij Mattijs S, Veldwijk Jorien, van Gils Paul, Mangen Marie-Josee J, Over Eelco, Suijkerbuijk Anita, Polder Johan, de Wit G Ardine, Opsteegh Marieke mrt 2019, In: Meat science. 149 , p. 1-8 8 p.

Cost-effectiveness of screening for chronic hepatitis B and C among migrant populations in a low endemic country

Suijkerbuijk Anita W.M., Van Hoek Albert Jan, Koopsen Jelle, De Man Robert A., Mangen Marie Josee J., De Melker Hester E., Polder Johan J., De Wit G. Ardine, Veldhuijzen Irene K. 1 nov 2018, In: PLoS ONE. 13

Updated cost-effectiveness and risk-benefit analysis of two infant rotavirus vaccination strategies in a high-income, low-endemic setting

Bruijning-Verhagen P, van Dongen J A P, Verberk J D M, Pijnacker R, van Gaalen R D, Klinkenberg D, de Melker H E, Mangen M-J J 10 sep 2018, In: BMC Medicine. 16

Sex-Related Differences in Patients With Inflammatory Bowel Disease:Results of 2 Prospective Cohort Studies

Severs Mirjam, Spekhorst Lieke M, Mangen Marie-Josée J, Dijkstra Gerard, Löwenberg Mark, Hoentjen Frank, van der Meulen-de Jong Andrea E, Pierik Marieke, Ponsioen Cyriel Y, Bouma Gerd, van der Woude Janneke C, van der Valk Mirthe E, Romberg-Camps Marielle J L, Clemens Cees H M, van de Meeberg Paul, Mahmmod Nofel, Jansen Jeroen, Jharap Bindia, Weersma Rinse K, Oldenburg Bas, Festen Eleonora A M, Fidder Herma H 21 apr 2018, In: Inflammatory bowel diseases. 24 , p. 1298-1306 9 p.

Impact of infectious diseases on population health using incidence-based disability-adjusted life years (DALYs):Results from the burden of communicable diseases in Europe study, European Union and European economic countries, 2009 to 2013

Cassini Alessandro, Colzani Edoardo, Pini Alessandro, Mangen Marie Josee J., Plass Dietrich, McDonald Scott A., Maringhini Guido, van Lier Alies, Haagsma Juanita A., Havelaar Arie H., Kramarz Piotr, Kretzschmar Mirjam E., 19 apr 2018, In: Eurosurveillance. 23 , p. 15-34 20 p.

The design of a Social Cost-Benefit Analysis of preventive interventions for toxoplasmosis:An example of the One Health approach

Suijkerbuijk Anita W M, van Gils P.F., Bonačić Marinović Axel, Feenstra T L, Kortbeek Laetitia M., Mangen M-J J, Opsteegh M, de Wit G A, van der Giessen J W B 12 nov 2017, In: Zoonoses and Public Health. 65 , p. 185-194

Clinical Predictors of Future Nonadherence in Inflammatory Bowel Disease

Severs Mirjam, Mangen Marie Josée J., Fidder Herma H., Van Der Valk Mirthe E., Van Der Have Mike, Van Bodegraven Ad A., Clemens Cees H M, Dijkstra Gerard, Jansen Jeroen M., de Jong Dirk J, Mahmmod Nofel, van de Meeberg Paul C, Van der Meulen-de Jong Andrea E, Pierik Marieke, Ponsioen Cyriel Y, Romberg-Camps Marielle J.L., Siersema Peter D., Jharap Bindia, van der Woude C Janneke, Zuithoff Nicolaas P.A., Oldenburg Bas sep 2017, In: Inflammatory bowel diseases. 23 , p. 1568-1576 9 p.

Targeted outreach hepatitis B vaccination program in high-risk adults:The fundamental challenge of the last mile

Mangen M. J.J., Stibbe H, Urbanus A., Siedenburg E C, Waldhober Q, de Wit G. A., Steenbergen Eric J, 31 mei 2017, In: Vaccine. 35 , p. 3215-3221 7 p.

All Research Output (71)